retatrutide name brand Demand for Unapproved Weight-Loss Drug Surges on Social Media 🎙️ NEW EPISODE: Retatrutide—The Triple

GLP-1 is a keystone hormone of metabolism with a wide range of metabolic effects, says Nicholas Norwitz, MD, a leading voice in the science of metabolic health

Beginning July 1, 2026, eligible Medicare beneficiaries can access four GLP-1 weight-loss medications through the temporary Medicare GLP-1 Bridge Program: Wegovy injections, Wegovy tablets, Zepbound KwikPen, and Foundayo

I cant do that. But no, not when you save the employer money, you prevent the need for expensive medications and you improve the health of their workers

The calculators activity multiplier captures this, but if your activity changes day to day or week to week, your needs will shift too